The Drug Controller General of India (DCGI) has authorised emergency use (EUA) for Zydus Lifesciences Ltd's novel Covid-19 vaccine, ZyCoV-D as a two-dose vaccine, the company announced on Tuesday.
With this approval, the vaccine will now be administered on day 0 and day 28. Earlier, the vaccine was approved in a three dose regimen to be administered on day 0, day 28 and day 56.
The approval will increase the compliance for the vaccine and reduce the overall time required for vaccination to improve immunity against the virus, said Dr. Sharvil Patel, managing director of Zydus Lifesciences. "It will also help in administering the vaccine in a larger population in a shorter time which is always desirable in the midst of a